Literature DB >> 7451652

Interactions between antibiotics and human neutrophils in the killing of staphylococci.

R K Root, R Isturiz, A Molavi, J A Metcalf, H L Malech.   

Abstract

Normal and antibiotic-pretreated staphylococci were incubated with human neutrophils to determine the interactions between cells and antimicrobials in the killing of the organisms. Staphylococcus aureus 502A pretreated during log-phase growth with subinhibitory ((1/4) minimum inhibiting concentration) (MIC) concentrations of penicillin G were more susceptible to killing by normal neutrophils than untreated bacteria (intracellular survival 0.17+/-0.04 vs. 1.5+/-0.38%, mean+/-SEM, respectively, at 35 min in 14 experiments; P < 0.01 by t test). Furthermore, this enhanced susceptibility to killing was observed even when phagosome formation was inhibited by cytochalasin B (65.6+/-4.6% pencillintreated vs. 30.5+/-4.5% untreated killed at 30 min in 14 experiments, P < 0.001). Pretreatment of S. aureus with vancomycin similarly enhanced susceptibility to killing by cytochalasin B-treated polymorphonuclear leukocytes (PMN), whereas pretreatment with gentamicin did not. The enchancement of killing by pretreatment with cell wall-active antibiotics was present in a dose-response fashion to 1/16th the MIC. It required specific antimicrobial activity; i.e., penicillin activity was inhibited by penicillinase or by incubation with bacteria at 4 degrees C. It also required active cellular metabolism and intact neutrophils. For antibiotic-pretreated bacteria to be killed by normal and cytochalasin B-treated cells, phagocytosis or binding to the cells was essential via a serum opsonindependent mechanism. In experiments with the cytochalasin B-treated cells, all bound penicillin-treated bacteria were killed vs. only a fraction (70%) of the bound untreated bacteria. Penicillin in 10 times the MIC had no direct effects on PMN phagocytic, metabolic, or microbicidal functions against a nonsusceptible organism, Candida albicans. The results indicate a cooperative effect between cell wall-active antibiotics at low concentrations and human PMN in the killing of staphylococci. The model establishes conditions for the study of the mechanisms involved in the cooperation of these bactericidal systems.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7451652      PMCID: PMC371594          DOI: 10.1172/JCI110020

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Effects of tetracycline on leukotaxis.

Authors:  R R Martin; G A Warr; R B Couch; H Yeager; V Knight
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

2.  Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis.

Authors:  S H Zigmond; J G Hirsch
Journal:  Exp Cell Res       Date:  1972-08       Impact factor: 3.905

3.  Effect of antibiotics on the bactericidal activity of human leukocytes.

Authors:  J W Alexander; R A Good
Journal:  J Lab Clin Med       Date:  1968-06

4.  Mechanism of action of gentamicin.

Authors:  F E Hahn; S G Sarre
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

5.  Improved tests for the evaluation of neutrophil function in human disease.

Authors:  J W Alexander; D B Windhorst; R A Good
Journal:  J Lab Clin Med       Date:  1968-07

6.  Interaction of intraleukocytic bacteria and antibiotics.

Authors:  G L Mandell
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

7.  Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes.

Authors:  R K Root; A S Rosenthal; D J Balestra
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

8.  Myeloperoxidase-mediated iodination by granulocytes. Intracellular site of operation and some regulating factors.

Authors:  R K Root; T P Stossel
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

9.  Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies.

Authors:  W Schaffner; M A Melly; J H Hash; M G Koenig
Journal:  Yale J Biol Med       Date:  1967-02

10.  Cytochalasin B reversibly inhibits phagocytosis: functional, metabolic, and ultrastructural effects in human blood leukocytes and rabbit alveolar macrophages.

Authors:  S E Malawista; J B Gee; K G Bensch
Journal:  Yale J Biol Med       Date:  1971-12
View more
  35 in total

1.  Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils.

Authors:  G L Mandell; E Coleman
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  In vitro simulation of in vivo conditions: physical state of the culture medium.

Authors:  V Lorian
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

3.  Mechanisms of interaction among subinhibitory concentrations of antibiotics, human polymorphonuclear neutrophils, and gram-negative bacilli.

Authors:  L A Mandell; M Afnan
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 4.  The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus.

Authors:  Elisabeth Hodille; Warren Rose; Binh An Diep; Sylvain Goutelle; Gerard Lina; Oana Dumitrescu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

5.  Therapeutic relevance of penicillin-induced hypersensitivity of Staphylococcus aureus to killing by polymorphonuclear leukocytes.

Authors:  C Lam; A Georgopoulos; G Laber; E Schütze
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

6.  Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  D P Speert; F Eftekhar; M L Puterman
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

7.  Influence of subinhibitory concentrations of antibiotics on opsonization and phagocytosis of Pseudomonas aeruginosa by human polymorphonuclear leukocytes.

Authors:  D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

8.  Detection and partial characterization of antibacterial factor(s) in alveolar lining material of rats.

Authors:  J D Coonrod; K Yoneda
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

9.  Interaction of beta-lactam antibiotics with the bactericidal activity of leukocytes against Escherichia coli.

Authors:  A Dalhoff
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

10.  Pharmacodynamic activity of a cephalosporin, Ro 40-6890, in human skin blister fluid: antibiotic activity in concert with host defense mechanisms.

Authors:  J F Hoogkamer; W H Hesse; S Sansano; W Zimmerli
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.